Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $56.00 and last traded at $55.72, with a volume of 428144 shares changing hands. The stock had previously closed at $49.70.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the stock. Fundamental Research set a $60.23 price target on shares of Zepp Health and gave the company a "buy" rating in a research report on Tuesday, August 26th. Wall Street Zen upgraded shares of Zepp Health to a "hold" rating in a report on Saturday, August 16th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Zepp Health in a research report on Saturday, September 27th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Zepp Health currently has an average rating of "Hold" and an average target price of $60.23.
View Our Latest Analysis on Zepp Health
Zepp Health Stock Performance
The company has a current ratio of 1.10, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $811.41 million, a price-to-earnings ratio of -11.59 and a beta of 1.32. The stock's 50 day moving average is $40.04 and its 200 day moving average is $16.58.
About Zepp Health
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.